Literature DB >> 23413146

A mouse model for human osteogenesis imperfecta type VI.

Rosalind Bogan1, Ryan C Riddle, Zhu Li, Sarvesh Kumar, Anjali Nandal, Marie-Claude Faugere, Adele Boskey, Susan E Crawford, Thomas L Clemens.   

Abstract

Osteogenesis imperfecta type VI (OI type VI) has recently be linked to a mutation in the SERPINF1 gene, which encodes pigment epithelium-derived factor (PEDF), a ubiquitously expressed protein originally described for its neurotrophic and antiangiogenic properties. In this study, we characterized the skeletal phenotype of a mouse with targeted disruption of Pedf. In normal mouse bone, Pedf was localized to osteoblasts and osteocytes. Micro-computed tomography (µCT) and quantitative bone histomorphometry in femurs of mature Pedf null mutants revealed reduced trabecular bone volume and the accumulation of unmineralized bone matrix. Fourier transform infrared microscopy (FTIR) indicated an increased mineral:matrix ratio in mutant bones, which were more brittle than controls. In vitro, osteoblasts from Pedf null mice exhibited enhanced mineral deposition as assessed by Alizarin Red staining and an increased mineral:matrix determined by FTIR analysis of calcified nodules. The findings in this mouse model mimic the principal structural and biochemical features of bone observed in humans with OI type VI and consequently provide a useful model with which to further investigate the role of PEDF in this bone disorder.
Copyright © 2013 American Society for Bone and Mineral Research.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23413146      PMCID: PMC3688658          DOI: 10.1002/jbmr.1892

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  37 in total

Review 1.  Guidelines for assessment of bone microstructure in rodents using micro-computed tomography.

Authors:  Mary L Bouxsein; Stephen K Boyd; Blaine A Christiansen; Robert E Guldberg; Karl J Jepsen; Ralph Müller
Journal:  J Bone Miner Res       Date:  2010-07       Impact factor: 6.741

Review 2.  New perspectives on osteogenesis imperfecta.

Authors:  Antonella Forlino; Wayne A Cabral; Aileen M Barnes; Joan C Marini
Journal:  Nat Rev Endocrinol       Date:  2011-06-14       Impact factor: 43.330

3.  Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta.

Authors:  Jutta Becker; Oliver Semler; Christian Gilissen; Yun Li; Hanno Jörn Bolz; Cecilia Giunta; Carsten Bergmann; Marianne Rohrbach; Friederike Koerber; Katharina Zimmermann; Petra de Vries; Brunhilde Wirth; Eckhard Schoenau; Bernd Wollnik; Joris A Veltman; Alexander Hoischen; Christian Netzer
Journal:  Am J Hum Genet       Date:  2011-02-25       Impact factor: 11.025

4.  Pigment epithelium-derived factor (PEDF) promotes tumor cell death by inducing macrophage membrane tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).

Authors:  Tsung-Chuan Ho; Show-Li Chen; Shou-Chuan Shih; Shing-Jyh Chang; Su-Lin Yang; Jui-Wen Hsieh; Huey-Chuan Cheng; Lee-Jen Chen; Yeou-Ping Tsao
Journal:  J Biol Chem       Date:  2011-08-16       Impact factor: 5.157

5.  Lack of cyclophilin B in osteogenesis imperfecta with normal collagen folding.

Authors:  Aileen M Barnes; Erin M Carter; Wayne A Cabral; MaryAnn Weis; Weizhong Chang; Elena Makareeva; Sergey Leikin; Charles N Rotimi; David R Eyre; Cathleen L Raggio; Joan C Marini
Journal:  N Engl J Med       Date:  2010-01-20       Impact factor: 91.245

Review 6.  Characterization of PEDF: a multi-functional serpin family protein.

Authors:  S Filleur; T Nelius; W de Riese; R C Kennedy
Journal:  J Cell Biochem       Date:  2009-04-01       Impact factor: 4.429

7.  Pigment epithelium-derived factor is an angiogenesis and lipid regulator that activates peroxisome proliferator-activated receptor alpha.

Authors:  Chuhan Chung; Jennifer A Doll; Veronica M Stellmach; John Gonzales; Sailesh Surapureddi; Mona Cornwell; Janardan K Reddy; Susan E Crawford
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

8.  Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia.

Authors:  Baozhi Yuan; Masanori Takaiwa; Thomas L Clemens; Jian Q Feng; Rajiv Kumar; Peter S Rowe; Yixia Xie; Marc K Drezner
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

9.  Anti-angiogenic pigment epithelium-derived factor regulates hepatocyte triglyceride content through adipose triglyceride lipase (ATGL).

Authors:  Chuhan Chung; Jennifer A Doll; Arijeet K Gattu; Christine Shugrue; Mona Cornwell; Philip Fitchev; Susan E Crawford
Journal:  J Hepatol       Date:  2007-12-26       Impact factor: 25.083

Review 10.  Measurement of the toughness of bone: a tutorial with special reference to small animal studies.

Authors:  R O Ritchie; K J Koester; S Ionova; W Yao; N E Lane; J W Ager
Journal:  Bone       Date:  2008-06-28       Impact factor: 4.398

View more
  24 in total

Review 1.  Bone biology: insights from osteogenesis imperfecta and related rare fragility syndromes.

Authors:  Roberta Besio; Chi-Wing Chow; Francesca Tonelli; Joan C Marini; Antonella Forlino
Journal:  FEBS J       Date:  2019-07-05       Impact factor: 5.542

2.  PEDF deficiency increases the susceptibility of rd10 mice to retinal degeneration.

Authors:  Shivani Dixit; Federica Polato; Marijana Samardzija; Mones Abu-Asab; Christian Grimm; Susan E Crawford; S Patricia Becerra
Journal:  Exp Eye Res       Date:  2020-07-25       Impact factor: 3.467

Review 3.  IFITM5 mutations and osteogenesis imperfecta.

Authors:  Nobutaka Hanagata
Journal:  J Bone Miner Metab       Date:  2015-06-02       Impact factor: 2.626

4.  Bone mineral properties in growing Col1a2(+/G610C) mice, an animal model of osteogenesis imperfecta.

Authors:  Marco Masci; Min Wang; Laurianne Imbert; Aileen M Barnes; Lyudmila Spevak; Lyudmila Lukashova; Yihe Huang; Yan Ma; Joan C Marini; Christina M Jacobsen; Matthew L Warman; Adele L Boskey
Journal:  Bone       Date:  2016-04-13       Impact factor: 4.398

5.  Targeting the LRP5 pathway improves bone properties in a mouse model of osteogenesis imperfecta.

Authors:  Christina M Jacobsen; Lauren A Barber; Ugur M Ayturk; Heather J Roberts; Lauren E Deal; Marissa A Schwartz; MaryAnn Weis; David Eyre; David Zurakowski; Alexander G Robling; Matthew L Warman
Journal:  J Bone Miner Res       Date:  2014-10       Impact factor: 6.741

6.  Determination of mesenchymal stem cell fate by pigment epithelium-derived factor (PEDF) results in increased adiposity and reduced bone mineral content.

Authors:  Arijeet K Gattu; E Scott Swenson; Yasuko Iwakiri; Varman T Samuel; Nancy Troiano; Ryan Berry; Christopher D Church; Matthew S Rodeheffer; Thomas O Carpenter; Chuhan Chung
Journal:  FASEB J       Date:  2013-07-25       Impact factor: 5.191

7.  Restoration of the serum level of SERPINF1 does not correct the bone phenotype in Serpinf1 null mice.

Authors:  Abbhirami Rajagopal; Erica P Homan; Kyu Sang Joeng; Masataka Suzuki; Terry Bertin; Racel Cela; Elda Munivez; Brian Dawson; Ming-Ming Jiang; Frank Gannon; Susan Crawford; Brendan H Lee
Journal:  Mol Genet Metab       Date:  2015-12-02       Impact factor: 4.797

8.  Contemporary Approaches for Identifying Rare Bone Disease Causing Genes.

Authors:  Charles R Farber; Thomas L Clemens
Journal:  Bone Res       Date:  2013       Impact factor: 13.567

9.  Pigment epithelium-derived factor restoration increases bone mass and improves bone plasticity in a model of osteogenesis imperfecta type VI via Wnt3a blockade.

Authors:  Glenn S Belinsky; Bharath Sreekumar; Jillian W Andrejecsk; W Mark Saltzman; Jingjing Gong; Raimund I Herzog; Samantha Lin; Valerie Horsley; Thomas O Carpenter; Chuhan Chung
Journal:  FASEB J       Date:  2016-04-28       Impact factor: 5.191

10.  A novel IFITM5 mutation in severe atypical osteogenesis imperfecta type VI impairs osteoblast production of pigment epithelium-derived factor.

Authors:  Charles R Farber; Adi Reich; Aileen M Barnes; Patricia Becerra; Frank Rauch; Wayne A Cabral; Alison Bae; Aaron Quinlan; Francis H Glorieux; Thomas L Clemens; Joan C Marini
Journal:  J Bone Miner Res       Date:  2014-06       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.